 Nutritional supplement Composition One capsule contains:- Isoflavons - 2 mg,
- Iron - 40 mg,
- Folic acid - 200 mcg,
- Hyaluronic acid - 3 mg,
- Vitamin C - 30 mg,
- Magnesium - 100 mg,
- Vitamin D3 - 2,5 mcg.
Recommendations for use:- to relieve the symptoms of menopause or premenstrual period, in case of cardiovascular diseases,
- to decrease the cholesterol concentration in blood and to improve bowel function.
Action of active substances Isoflavones
Isoflavones are called natural estrogens because they bind to the estrogen receptors and act similar to estrogen.
Isoflavones relieve the symptoms of menopause, regulate hormone level during the premenopausal period, are
effective in case of osteoporosis. Isoflavones - genistein and daidzein have antioxidative and phytoestrogenic
properties. Isoflavones may help to prevent malignant diseases, to reduce blood cholesterol level significantly,
improve blood circulation, relieve inflammation, strengthen immunity.
Iron and folic acid are essential for the production of red blood cells, to help maintain energy levels, health and
vitality. Vitamin C Vitamin C, that is nessesary for iron absorbtion, together with hyaluronic acid required for skin to maintain moisture
and elasticity. Vitamin C (ascorbic acid) enhances iron absorption. Vitamin C (ascorbic acid) participates in
various physiologic processes of the organism: metabolism of connective tissue, synthesis of glucosaminoglycans,
strengthens immune system, participates in the metabolism of cholesterol, distinguishes for antioxidative
features, strengthens walls of the vessels, necessary for iron adoption. The demand of vitamin C increases in
case of frequent and permanent stress, while smoking, having infectious diseases, for elder people, while eating
an inferior food.
Vitamin C of prolonged effect is absorbed faster, it has bigger concentration in plasma, but it is slowlier released
from the organism, i.e. it is detected in the urine later than usual vitamin C. Thus vitamin C of prolonged effect
stays in the organism 2-3 times longer. Vitamin D3
One of the main functions of Vitamin D3 includes regulation of calcium, magnesium and phosphorus circulation.
Vitamin D3 helps to retain these substances in bones, combats atherosclerosis. Vitamin D deficiency results in
softening of bones, disorders of teeth growth. Magnesium
Magnesium is one of the most important minerals. It participates in the nervous system activity, thermoregulation processes, regulates heart contraction rate and power, relaxes muscles. Magnesium is required to facilitate the menopause-induced ailments.
Dosage 1 capsule 2 times a day. Literatūra: 1.Cassidy A, Bingham S, Setchell KDR. Biological effects of soy protein rich in isoflavones on menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60:333-340.
2.Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333(5):276-282.
3.Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr. 2003;57(8):940-946.
4.Squadrito F, Altavilla D, Crisafulli A, et al. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med. 2003;114(6):470-476.
5. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997;17(12):3392-3398.
6. Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre M. A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause. 2001;8(5):338-346.
7.Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol. 2000;85(11):1297-1301.
8.Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr. 2003;78(1):123-130.
9. DeLuca HF and Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998;56:S4-10. [PubMed abstract]
10. Reichel H, Koeffler H, Norman AW. The role of vitamin D endocrine system in health and disease. N Engl J Med 1989;320:980-91. [PubMed abstract]
11. van den Berg H. Bioavailability of vitamin D. Eur J Clin Nutr 1997;51 Suppl 1:S76-9. [PubMed abstract]
12. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press, Washington, DC, 1999.
13. Shils ME. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins, 1999.
14. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington DC: The National Academies Press, 1997.
15. U.S. Department of Agriculture. Results from the United States Department of Agriculture's 1994-96 Continuing Survey of Food Intakes by Individuals/Diet and Health Knowledge Survey. 1994-96. http://www.barc.usda.gov/bhnrc/foodsurvey/Products9496.html#foodandnutrientintakes.
16. Subar AF, Krebs-Smith SM, Cook A, Kahle LL. Dietary sources of nutrients among US adults. J Am Diet Assoc 1998;98:537-47.
17. U.S. Department of Agriculture ARS. USDA Nutrient Database for Standard Reference Release 19. Nutrient Data Laboratory Home Page. 2003. http://www.nal.usda.gov/fnic/foodcomp.
18. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 1997;10:149–56.
20. Paolisso G, Scheen A, D’Onofrio FD, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990;33:511–4 [review].
19. Eibl NL, Schnack CJ, Kopp H-P, et al. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy.
21. Moorkens G, Manuel y Keenoy B, Vertommen J, et al. Magnesium deficit in a sample of the Belgian population presenting with chronic fatigue. Magnes Res 1997;10:329–37.
22. Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991;337:757–60.
23. Howard JM, Davies S, Hunnisett A. Magnesium and chronic fatigue syndrome. Lancet 1992;340:426.
24. NM. Magnesium and chronic fatigue. Lancet 1991;338:66 [letter].
25. Hinds G, Bell NP, McMaster D, McCluskey DR. Normal red cell magnesium concentrations and magnesium loading tests in patients with chronic fatigue syndrome. Ann Clin Biochem 1994;31(Pt 5):459–61. |
